BULGARIA'S DOVERIE OBEDINEN HOLDING PLANS CAPITAL HIKE
Bulgaria's former privatisation fund Doverie Obedinen Holding, controlled by pharmaceutical group Sopharma, plans to raise 8.05 million leva from its shareholders through a capital increase, the company said.
The move, approved by Doverie's board of directors on July 19, envisions boosting the company's capital to 16.3 million leva from 14 million leva.
The company will issue 2.3 million new shares at a price of 3.5 leva each. The capital hike will be considered successful if at least 1.5 million of the shares are subscribed for.
The transaction will be managed by investment intermediary Sofia International Securities. The capital hike is currently pending approval from the Financial Supervision Commission.
Readed: 485
